BCL2L11 and plasma cell myeloma: Similarly, combining obatoclax with the pan-CDK inhibitor flavopiridol increased apoptosis of both drug-naïve and drug-resistant multiple myeloma cells in a Bim- and Noxa-dependent mechanism [613].